Article By:
ChinaBio® Today
Sunday, March 1, 2015 5:52 PM EDT
Eddingpharm, a China in-licensing company, signed a deal worth up to $169 million for China rights to Vascepa®, a prescription omega-3 drug from Amarin Corp and more Pharma/Biotech news.